One of the fields of activity of the company "Inogene" is development of test systems for molecular genetic diagnosis of cancer in order to assess the prognosis of disease and the effectiveness of therapy.

 We offer Kits for:

  •  the study of genetic factors associated with the likelihood of developing the disease (ovarian cancer and breast cancer)
  •  genetic factors evaluation of prognostic significance that determine the course of disease (acute leukemia)
  •  molecular markers evaluation that define the sensitivity to therapy (lung cancer, chronic myeloid leukemia)
  •  evaluation of the effectiveness of therapy – minimal residual disease (MRD) detection (acute leukemia, chronic myeloid leukemia)
  •  assessment of  donor cells engraftment - donor chimerism (during hematopoietic stem cell transplantation). This system can also be used in the investigation of the kinship existence

 The developed test system advantageously adapted for use as capillary sequencer and the devices with the detection of the amplification products in real time, with respect to most available diagnostic laboratories now quite common.

 The main advantages of the use of reagents Inogene:

  •  ability to adapt the test systems for any equipment (fluorescent Real-time PCR amplifiers, Sanger sequencers)  
  •  ability to conduct training for working with the test systems, including on-site at the customer's laboratory
  • possible development of custom test system
© Inogene LLC 2020